Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia.
about
Familial hypercholesterolemia: an under-recognized but significant concern in cardiology practiceFamilial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis SocietyApoB100/LDLR-/- hypercholesterolaemic mice as a model for mild cognitive impairment and neuronal damageUS physician practices for diagnosing familial hypercholesterolemia: data from the CASCADE-FH registry.Serious drug-induced liver disease secondary to ezetimibe.A tailored lifestyle intervention to reduce the cardiovascular disease risk of individuals with Familial Hypercholesterolemia (FH): design of the PRO-FIT randomised controlled trial.Risk stratification of patients with familial hypercholesterolemia in a multi-ethnic cohort.A genetic variant in the LDLR promoter is responsible for part of the LDL-cholesterol variability in primary hypercholesterolemiaGenomic characterization of large rearrangements of the LDLR gene in Czech patients with familial hypercholesterolemiaHigher incidence of mild cognitive impairment in familial hypercholesterolemia.Familial hypercholesterolemia: A reviewEfficacy and safety of alirocumab in patients with heterozygous familial hypercholesterolemia not adequately controlled with current lipid-lowering therapy: design and rationale of the ODYSSEY FH studies.Heterozygous Familial Hypercholesterolemia With APOE Haplotype: A Prospective Harbinger of a Catastrophic Cardiovascular Event.Single step PCR for the identification of Low Density Lipoprotein Receptor (LDL-R) gene mutations.Association of peripheral arterial and cardiovascular diseases in familial hypercholesterolemia.No significant improvement of cardiovascular disease risk indicators by a lifestyle intervention in people with familial hypercholesterolemia compared to usual care: results of a randomised controlled trialRandomized, placebo-controlled trial of mipomersen in patients with severe hypercholesterolemia receiving maximally tolerated lipid-lowering therapy.Heterozygous familial hypercholesterolemia: an underrecognized cause of early cardiovascular disease.Can multiple lifestyle behaviours be improved in people with familial hypercholesterolemia? Results of a parallel randomised controlled trialFamilial hypercholesterolemia: current treatment and advances in management.Familial hypercholesterolemia: the lipids or the genes?Mortality among patients with familial hypercholesterolemia: a registry-based study in Norway, 1992-2010.Clinical characteristics and evaluation of LDL-cholesterol treatment of the Spanish Familial Hypercholesterolemia Longitudinal Cohort Study (SAFEHEART)Animal models of calcific aortic valve diseaseGenetic diagnosis of familial hypercholesterolaemia by targeted next-generation sequencing.Premature coronary artery disease and familial hypercholesterolemia: need for early diagnosis and cascade screening in the Indian population.Effects of Smad decoy ODN on shear stress-induced atherosclerotic ApoE-/-mouse.Familial Hypercholesterolemia: a Review of the Natural History, Diagnosis, and ManagementA model of care for familial hypercholesterolaemia: key role for clinical biochemistry.Physical activity and atherosclerosis: which animal model?Into the wardrobe of Narnia: beyond HIV infection a world of cardiovascular risk.Benefits and risks assessment of simvastatin in familial hypercholesterolaemia.Reducing the burden of disease and death from familial hypercholesterolemia: a call to actionPractical guidelines for familial combined hyperlipidemia diagnosis: an up-date.Development of Aortic Valve Disease in Familial Hypercholesterolemic Swine: Implications for Elucidating Disease EtiologyThe Draupadi of dyslipidemia: Familial hypercholesterolemiaThe genetic basis of familial hypercholesterolemia: inheritance, linkage, and mutations.Genetic screening for homozygous and heterozygous familial hypercholesterolemiaDifferent lipid profiles according to ethnicity in the Heart of Soweto study cohort of de novo presentations of heart disease.Exploring Gaps of Family History Documentation in EHR for Precision Medicine -A Case Study of Familial Hypercholesterolemia Ascertainment
P2860
Q26828401-EFD7C260-B9C2-4CE1-A251-3C34576786ACQ27024882-260993CF-D00A-4807-A9CF-05C0411B87ECQ28742107-F7C320BE-34FF-48D8-8DF7-272FD89A6D8EQ31133478-1BDFA5E4-9CCC-4439-9803-76676FB489C1Q33365589-26B07CF7-CAF1-4DAA-B1F3-0F83A493E5BFQ33531339-7280478A-D251-4291-AE8F-661BC1449E38Q33593043-F5BA930B-8156-4CFF-A4D2-E82405A6AA09Q33614636-D33ADB3B-3536-465E-839D-89743D940DD2Q33642312-636A38A2-0476-466B-A3B4-2400B0760F2DQ33750064-00DF203E-AC22-4089-80F3-77F629A8DB1BQ33803782-740FAA18-20EF-4E7F-9BCE-F4184E3AE36AQ33818871-799D8811-F034-463B-A3C1-7CFB089D0C65Q33893915-E1EF96C6-6479-4DAD-9C2B-78A5D3FA1231Q34001978-DABD5F87-CF57-416F-A6AC-19674F40ADF6Q34114953-41E337A0-DC2B-495F-8F83-F055288F926EQ34227238-D899994E-6492-4340-AE84-CC5B0B10A6A6Q34477657-26178647-BE1D-4964-9936-4C0169558EB7Q34499298-2A192D8E-6C89-4761-8E90-17AC511204F0Q34515713-8499A43E-F167-4227-B8F6-2E9A0C4C5A02Q34769059-8CF66AC8-068E-44E5-8F13-621757CA14F6Q35014525-EF079B61-3B33-4320-B9E8-D03C26430489Q35114991-CE82BC8F-A405-47CF-B26D-F84E546F0F48Q35121832-E21EF0C5-4B14-43CF-8C82-E84DAD180B1DQ35147157-0CE83799-4049-4CF2-A664-6C809C315BF7Q35204454-EE0DA67E-95B9-41A3-8D3D-B26A2128ECB1Q35494775-D14BB506-8FFB-4B27-A614-087DE2ADF22CQ35741094-567EA76A-316A-4112-AA3B-A688B63454EBQ35756629-7DFC817B-E54B-4469-AFF3-EEB323ACD50EQ35771729-7AB5A360-4BD4-4AA9-9152-7577152125B0Q35944971-B948C53E-D97E-4110-8F7F-0CB2408E81A6Q35975760-CD6B8D8E-08F9-4290-9213-43D2B1D35B95Q36081978-F8FF274B-4472-4A0B-A324-C9A77B7C0626Q36381467-9348A68E-613A-4E71-A662-D84058A33249Q36596847-6E4F0159-7CDC-4F60-A53A-9234378914CEQ36836059-91A36701-DC34-4D6D-B352-62DFBD74BC85Q36867393-6C527D04-EDAA-419E-A965-9D2CADB84A9DQ36925157-868D7C10-EA31-46D8-8085-0E297BF63710Q36925180-0AD9FA11-6C52-4BBB-BD31-B07294F64BADQ37041696-91E71D99-A11E-4534-B8D7-BFA4A0AD8478Q37211293-F7103358-626C-4386-A2F0-22F34C6FAD62
P2860
Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Guidelines for the diagnosis a ...... familial hypercholesterolemia.
@ast
Guidelines for the diagnosis a ...... familial hypercholesterolemia.
@en
type
label
Guidelines for the diagnosis a ...... familial hypercholesterolemia.
@ast
Guidelines for the diagnosis a ...... familial hypercholesterolemia.
@en
prefLabel
Guidelines for the diagnosis a ...... familial hypercholesterolemia.
@ast
Guidelines for the diagnosis a ...... familial hypercholesterolemia.
@en
P1433
P1476
Guidelines for the diagnosis a ...... familial hypercholesterolemia.
@en
P2093
Fernando Civeira
International Panel on Management of Familial Hypercholesterolemia
P356
10.1016/J.ATHEROSCLEROSIS.2003.11.010
P577
2004-03-01T00:00:00Z